CHICAGO — Caribou’s off-the-shelf cell therapy appears poised to break free from the rapid relapses that have plagued other off-the-shelf cell therapies, according to a …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Bolt Biotherapeutics is reshuffling to cut costs and extend its cash runway to the second half of 2026. The California biotech said Tuesday afternoon that
WASHINGTON (AP) — The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the U.S., under
Australian patients with chronic health issues prescribed medical cannabis showed significant improvements in overall health-related quality of life and fatigue in the first three months